DMAC icon

DiaMedica Therapeutics
DMAC

Overview Fund Activity

28 hedge funds and large institutions have $7.42M invested in DiaMedica Therapeutics in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 7 closing their positions.

Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
6
Closed
7
Calls
$175K
Puts
$57K
Net Calls
+$118K
Net Calls Change
+$48K

Top Buyers

1
CF
1
Cantor Fitzgerald
New York
$30K
2
Morgan Stanley
2
Morgan Stanley
New York
$96K
3
BlackRock
3
BlackRock
New York
$135K
4
Geode Capital Management
4
Geode Capital Management
Massachusetts
$357K
5
UBS Group
5
UBS Group
Switzerland
$6K

Top Sellers

1
IC
1
Ikarian Capital
Texas
$0
2
Two Sigma Investments
2
Two Sigma Investments
New York
$35K
3
JAMONY
3
Jacob Asset Management of New York
California
$482K
4
BFM
4
Boothbay Fund Management
New York
$0
5
Two Sigma Advisers
5
Two Sigma Advisers
New York
$54K
Name Holding Trade Value Shares
Change 		Shares
Change %
IC
26
Ikarian Capital
Texas
– -$553K -221,252 Closed
BFM
27
Boothbay Fund Management
New York
– -$52K -20,603 Closed
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
– -$41K -16,324 Closed
SCA
29
Sandy Cove Advisors
Massachusetts
– -$3K -1,200 Closed
Citigroup
30
Citigroup
New York
– -$1K -273 Closed
1
2